Form 4 for CRBP Corbus Pharmaceuticals Holdings, Inc.
Accepted 2024-06-14 00:00:00 ET · period of report 2024-06-14 · accession 0000950170-24-073710 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-14 | 2024-06-14 | CRBP | HOLMER ALAN F | Dir | M - OptEx | $30.00 | +1,667 | 5,829 | +40% | +$50.0K |
| D | 2024-06-14 | 2024-06-14 | CRBP | HOLMER ALAN F | Dir | M - OptEx | $0.00 | -1,667 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 per share | 2024-06-14 | M | A | 1,667 | $30.00 | 5,829 | D | — | — | (F1) This amount includes 2,783 unvested RSUs that were granted on May 30, 2024 and will vest 100% on the one-year anniversary from the date of grant. |
| 2 | Derivative | Options to purchase common stock | 2024-06-14 | M | D | 1,667 | $0.00 | 0 | D | $30.00 · — to 2024-07-09 | 1,667 Common Stock | (F2) The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan and is fully vested. |